WARRANT AGREEMENTWarrant Agreement • November 10th, 2016 • Xtant Medical Holdings, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 10th, 2016 Company Industry JurisdictionTHIS WARRANT AGREEMENT (this “Agreement”), dated as of _________, 2016, is by and between Xtant Medical Holdings, Inc., a Delaware corporation (the “Company”), and Corporate Stock Transfer, Inc., as the Warrant Agent (the “Warrant Agent”).
WARRANT AGREEMENTWarrant Agreement • October 28th, 2016 • Xtant Medical Holdings, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledOctober 28th, 2016 Company Industry JurisdictionTHIS WARRANT AGREEMENT (this “Agreement”), dated as of _________, 2016, is by and between Xtant Medical Holdings, Inc., a Delaware corporation (the “Company”), and Corporate Stock Transfer, Inc., as the Warrant Agent (the “Warrant Agent”).
WARRANT AGREEMENTWarrant Agreement • October 21st, 2016 • Xtant Medical Holdings, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledOctober 21st, 2016 Company Industry JurisdictionTHIS WARRANT AGREEMENT (this “Agreement”), dated as of _________, 2016, is by and between Xtant Medical Holdings, Inc., a Delaware corporation (the “Company”), and Corporate Stock Transfer, Inc., as the Warrant Agent (the “Warrant Agent”).
FORM OF WARRANT AGREEMENTWarrant Agreement • July 1st, 2016 • Onconova Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 1st, 2016 Company Industry JurisdictionTHIS WARRANT AGREEMENT (this “Agreement”), dated as of July , 2016, is by and between Onconova Therapeutics, Inc., a Delaware corporation (the “Company”), and Wells Fargo Bank, N.A., as the Warrant Agent (the “Warrant Agent”).